Arzeda Stock
Arzeda develops enzyme design technology to create entirely novel designer cell factories capable of industry-scale chemical production.
Sign up today and learn more about Arzeda Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Arzeda Stock
Arzeda develops enzyme design technology that presents a new way of thinking about biocatalysis. The company was founded by David Baker and three senior members of his lab to commercialize and further develop its computational enzyme design technology.
Funding History
| February 2009 | $0 |
|---|---|
| July 2017 | $12.0M |
| November 2017 | $3.2M |
Management
Co-Founder & CEO
Alexandre Zanghellini
Co-Founder & CSO
Daniela Grabs
Co-Founder & CBO
Eric Althoff
Press
patents - Apr, 14 2024
Compositions and methods for producing rebaudioside mpatents - Apr, 14 2024
Compositions and methods for producing steviol glycosidespatents - Apr, 14 2024
Methods and compositions for preparing tagatose from fructosepatents - Apr, 14 2024
Automated method of computational enzyme identification and designpatents - Apr, 14 2024
Compositions and methods for producing rebaudioside dEquityZen Recognized As:
